Skip to main content
Clinical Trials/ACTRN12620000212954
ACTRN12620000212954
Completed
未知

An investigation into the anxiety- and stress-relieving effects of Echinacea angustifolia (EP107™): a randomised, double-blind, placebo-controlled study

Clinical Research Australia0 sites108 target enrollmentFebruary 21, 2020

Overview

Phase
未知
Intervention
Not specified
Conditions
Anxiety
Sponsor
Clinical Research Australia
Enrollment
108
Status
Completed
Last Updated
5 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
February 21, 2020
End Date
July 30, 2020
Last Updated
5 years ago
Study Type
Interventional
Sex
All

Investigators

Sponsor
Clinical Research Australia

Eligibility Criteria

Inclusion Criteria

  • 1\. Healthy adults (male and female) between 18 and 65
  • 2\. Experiencing mild\-to\-moderate severity of stress/anxiety (score between 11 and 40 on the CUXOS)
  • 3\. Stressor/anxiety has been present for greater than a month
  • 4\. Medication\-free for at least 3 months. Use of analgesics (once a week) or contraceptive pill are permissible.
  • 5\. Non\-smoker
  • 6\. BMI between 20 and 35
  • 7\. No plan to commence new treatments over study period
  • 8\. Willing to provide a personally signed informed consent form detailing all pertinent aspects of the trial.
  • 9\. Willing and able to take prescribed tablets for 6 weeks

Exclusion Criteria

  • 1\. Alcohol consumption \> 14 standard drinks per week
  • 2\. Current or 12\-month history of illicit drug abuse
  • 3\. Pregnant women, women who are breastfeeding or women who intended to fall pregnant.
  • 4\. Suffering from medical conditions including but not limited to: gastrointestinal disease, functional gastrointestinal disorder, diabetes, hyper/hypotension, cardiovascular disease, gallbladder disease/gallstones/biliary disease, endocrine disease, psychiatric disorder (other than mild\-to\-moderate anxiety), and neurological disease (Parkinson’s, Alzheimer’s disease, intracranial haemorrhage, head or brain injury)
  • 5\. Currently taking supplements that may impact on treatment outcome

Outcomes

Primary Outcomes

Not specified

Similar Trials